SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-19-130940
Filing Date
2019-05-01
Accepted
2019-05-01 08:02:19
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d734707ds3.htm S-3 448462
2 EX-1.2 d734707dex12.htm EX-1.2 189397
3 EX-4.2 d734707dex42.htm EX-4.2 299329
4 EX-4.3 d734707dex43.htm EX-4.3 298029
5 EX-5.1 d734707dex51.htm EX-5.1 13702
6 EX-5.2 d734707dex52.htm EX-5.2 6431
7 EX-23.1 d734707dex231.htm EX-23.1 1428
8 GRAPHIC g734707g01g21.jpg GRAPHIC 50036
9 GRAPHIC g734707g12z97.jpg GRAPHIC 49063
10 GRAPHIC g734707g54l52.jpg GRAPHIC 97163
11 GRAPHIC g734707g55a58.jpg GRAPHIC 36985
  Complete submission text file 0001193125-19-130940.txt   1578897
Mailing Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139 617-714-4096
Surface Oncology, Inc. (Filer) CIK: 0001718108 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-231144 | Film No.: 19784858
SIC: 2836 Biological Products, (No Diagnostic Substances)